-
ENSC Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Ensysce Biosciences (ENSC)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 4.15 mm | 4.15 mm | 4.15 mm | 4.15 mm | 4.15 mm | 4.15 mm |
Cash burn (monthly) | (no burn) | (no burn) | (no burn) | 525.78 k | 340.11 k | 711.71 k |
Cash used (since last report) | n/a | n/a | n/a | 1.47 mm | 949.00 k | 1.99 mm |
Cash remaining | n/a | n/a | n/a | 2.69 mm | 3.20 mm | 2.17 mm |
Runway (months of cash) | n/a | n/a | n/a | 5.1 | 9.4 | 3.0 |
13F holders | Current |
---|---|
Total holders | 11 |
Opened positions | 4 |
Closed positions | 5 |
Increased positions | 1 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 712.73 mm |
Total shares | 6.99 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Silvers Daniel B. | 2.88 mm | $2.50 mm |
Hydra LAC | 1.87 mm | $27.07 mm |
Lincoln Park Capital Fund | 1.50 mm | $1.17 mm |
CVI Investments | 336.87 k | $0.00 |
Sabby Management | 322.30 k | $580.14 mm |
Anson Funds Management | 36.26 k | $65.27 mm |
Gsa Capital Partners | 17.55 k | $32.00 k |
Vanguard | 15.42 k | $27.75 mm |
Tower Research Capital | 3.90 k | $7.02 mm |
BLK BlackRock | 975.00 | $1.76 mm |